Archives
-
Nurr1+ Neuron Birthdating in the Rat Claustrum
2026-08-16
Fang, Wang, and Naumann mapped the developmental emergence and embryonic birthdating of Nurr1-positive neurons across the rat claustrum, endopiriform nucleus, and lateral cortex. Their combination of developmental Nurr1 expression analysis with EdU labeling and in situ hybridization revealed region-specific birth windows and previously under-characterized spatial neurogenetic gradients.
-
5-Methyl-CTP: An Assay-First mRNA Guide
2026-08-15
5-Methyl-CTP can help researchers test enhanced mRNA stability and improved mRNA translation efficiency in controlled in vitro transcription workflows. This assay-first guide connects nucleotide selection with translational evidence from an H5N1 mRNA vaccine study while clearly separating demonstrated findings from practical recommendations.
-
CTP Solution (100 mM): IVT Reliability
2026-08-14
A scenario-driven guide to using CTP Solution (100 mM), SKU K1045, in in vitro transcription and mRNA-LNP workflows that support proliferation, viability, and cytotoxicity studies. It explains stock handling, compatibility checks, data interpretation, and practical vendor-selection criteria.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-08-14
Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 supports research detection of HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It is an unconjugated research reagent, not a diagnostic or therapeutic product, and assay-specific dilution and fixation conditions should be validated in the user’s system.
-
Recombinant Annexin V Purification for Biophysics
2026-08-13
Burger and colleagues introduced a short purification strategy for recombinant annexin V that combined gentle osmotic shock, reversible calcium-dependent liposome binding, and final ion-exchange chromatography. The resulting purity, assessed by silver-stained SDS-PAGE and HPLC, was intended to support crystallography, electron microscopy, spectroscopy, and single-channel measurements.
-
Nile Red for Lipid Phenotyping in Laryngeal Cancer
2026-08-13
Nile Red enables wavelength-selective visualization of cellular lipid droplets and membranes. This article presents a distinctive framework for connecting lipid phenotypes with THBS1-centered laryngeal cancer research while separating validated evidence from hypothesis-generating assay design.
-
CTP Solution: From Nucleotide to mRNA Assay
2026-08-12
CTP Solution (100 mM) supports controlled RNA synthesis and downstream mRNA-LNP research. This article traces how nucleotide quality, reaction design, and assay interpretation connect without overstating what current bladder cancer evidence proves.
-
Self-Amplifying RNA Vaccines for Influenza
2026-08-12
This study shows that self-amplifying RNA can overcome the subtype-dependent immunogenicity limitations observed with conventional mRNA influenza vaccines, particularly for influenza B. In mice, a 0.1 μg trivalent saRNA dose produced durable antibody responses and complete protection against influenza B challenge, supporting dose-sparing development while highlighting the need for careful platform and antigen optimization.
-
Concanavalin A Blocks Conserved Coronavirus Entry
2026-08-11
The reference study identifies conserved high-mannose N-glycans near the coronavirus spike S2′ cleavage site as a broad-spectrum antiviral vulnerability. Using fusion, pseudovirus, authentic-virus, biochemical, and animal models, the authors show that concanavalin A blocks spike activation and reduces hCoV-NL63 disease in vivo.
-
5-Methyl-CTP for Modified mRNA Workflows
2026-08-11
5-Methyl-CTP gives researchers a practical way to test methylated cytidine incorporation during IVT, with applications ranging from reporter assays to personalized mRNA vaccine development. This guide connects nucleotide selection with RNA quality control, translation testing, and the OMV-based antigen-display strategy described in a recent Advanced Materials study.
-
5-Methyl-CTP for Better mRNA Assays
2026-08-10
Learn how 5-Methyl-CTP connects modified mRNA synthesis with assay design, quality control, and delivery interpretation. This evidence-grounded guide explains how to evaluate enhanced mRNA stability and translation without confusing nucleotide chemistry with carrier performance.
-
BIBR 1532: Telomerase Inhibitor Workflows
2026-08-09
BIBR 1532 enables selective interrogation of hTERT-driven telomerase biology across proliferation, transcription, and apoptosis assays. This workflow guide shows how to separate rapid pathway effects from slower telomere attrition and adapt synergy-focused assay logic from recent cancer research.
-
Toremifene Workflows for Prostate Cancer Research
2026-08-08
Build hormone-aware prostate cancer experiments around Toremifene while separating estrogen-receptor effects from calcium-dependent migration and invasion. This practical guide combines dose-response design, STIM1/TSPAN18 pathway assays, xenograft study planning, and troubleshooting for reproducible translational workflows.
-
GLI2 Links WNT Signaling to Immunotherapy Resistance
2026-08-07
The reference study identifies GLI2 as a mechanistic coordinator of WNT ligand production and prostaglandin signaling during mesenchymal transformation, creating an immune-suppressive tumor microenvironment. Its findings connect tumor-cell plasticity with myeloid suppression, impaired cytotoxic lymphocyte activity, and resistance to anti-PD-1 therapy, suggesting rational combination strategies for preclinical cancer research.
-
Sodium Overload Impairs Mitochondrial Metabolism via NECSO M
2026-08-07
Qiao et al. (2025) reveal how sodium influx, mediated by TRPM4 channels, disrupts mitochondrial energy metabolism and triggers necrosis through the NECSO pathway. Their mechanistic insights clarify the link between sodium dysregulation, mitochondrial dysfunction, and cell fate, highlighting new avenues for disease modeling and apoptosis research.